Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > JANX Janux Therapeutics > Detailed Quotes

JANX Janux Therapeutics

13.750
+0.020+0.15%
Trading Session 10/05 11:13 ET
High
14.850
Open
13.600
Turnover
31.16K
Low
12.870
Pre Close
13.730
Volume
2.27K
Market Cap
572.87M
P/E(TTM)
Loss
52wk High
29.510
Shares
41.66M
P/E(Static)
Loss
52wk Low
9.390
Float Cap
195.70M
Bid/Ask %
33.33%
Historical High
37.990
Shs Float
14.23M
Volume Ratio
0.11
Historical Low
9.390
Dividend TTM
--
Div Yield TTM
--
P/B
1.67
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.02%
Amplitude
14.42%
Avg Price
13.737
Lot Size
1
Float Cap
195.70M
Bid/Ask %
33.33%
Historical High
37.990
Shs Float
14.23M
Volume Ratio
0.11
Historical Low
9.390
Dividend TTM
--
P/B
1.67
Dividend LFY
--
Turnover Ratio
0.02%
Amplitude
14.42%
Avg Price
13.737
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
CEO: Dr. David Campbell, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...